
Human IL-2 PicoKine ELISA Kit standard curve
Human IL-2/Interleukin-2 ELISA Kit PicoKine(r)
EK0397
Product group Assays
Overview
- SupplierBoster Bio
- Product NameHuman IL-2 PicoKine ELISA Kit
- Delivery Days Customer9
- ApplicationsELISA
- Applications SupplierELI
- Assay Detection Range15.6 pg/ml - 1,000 pg/ml
- Assay Sensitivity<1 pg/ml
- Assay Time15-20
- CertificationResearch Use Only
- Scientific DescriptionHuman IL-2/Interleukin-2 ELISA Kit PicoKine® (96 Tests). Quantitate Human IL2 in cell culture supernatants, serum and plasma ( heparin, EDTA, citrate). Sensitivity: 1pg/ml. The brand Picokine indicates this is a premium quality ELISA kit. Each Picokine kit delivers precise quantification, high sensitivity, and excellent reproducibility. Only our most reliable and effective kits qualify as Picokine, guaranteeing top-tier results for your assays.
- Reactivity SupplierHuman IL-2
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC41116158
References
- Sarmin N, Roknuzzaman ASM, Sarker R, et al. Association of interleukin-2 and interleukin-10 with the pathophysiology and development of generalized anxiety disorder: a case-control study. BMC Psychiatry. 2024,24(1):462. doi: 10.1186/s12888-024-05911-zRead this paper
- Wang C, Zhang H, Liu T, et al. Circulating Tfr/Tfh cell imbalance may contribute to the immunopathogenesis of pemphigus. J Eur Acad Dermatol Venereol. 2023,37(12):e1399-e1402. doi: 10.1111/jdv.19338Read this paper
- Banerjee T, Rai S, Singh A, et al. Poor Glycemic Control Is Associated With Lower Interleukin-2 (IL-2) Levels and Low Macrophage Viability in Chronic Diabetic Foot Ulcers (DFUs). Int J Low Extrem Wounds. 2023,:15347346231182793. doi: 10.1177/15347346231182793Read this paper
- Chen X, Wang S, Chen Y, et al. Non-invasive activation of intratumoural gene editing for improved adoptive T-cell therapy in solid tumours. Nat Nanotechnol. 2023,18(8):933-944. doi: 10.1038/s41565-023-01378-3Read this paper
- Xu J, Yang G, An W, et al. Correlations between the severity of radiation-induced oral mucositis and salivary epidermal growth factor as well as inflammatory cytokines in patients with head and neck cancer. Head Neck. 2023,45(5):1122-1129. doi: 10.1002/hed.27313Read this paper
- Zhang Y, Yang S, Jiang D, et al. Screening and identification of an anti-PD-1 nanobody with antitumor activity. Biosci Rep. 2022,43(1). doi: 10.1042/BSR20221546Read this paper
- Cheng L, Zhou S, et al. Dual Inhibition of CDK12/CDK13 Targets Both Tumor and Immune Cells in Ovarian Cancer. Cancer Res. 2022,82(19):3588-3602. doi: 10.1158/0008-5472.CAN-22-0222Read this paper
- Wang J, Ge J, Wang Y, et al. EBV miRNAs BART11 and BART17-3p promote immune escape through the enhancer-mediated transcription of PD-L1. Nat Commun. 2022,13(1):866. doi: 10.1038/s41467-022-28479-2Read this paper
- Kozachok S, Kolodziejczyk-Czepas J, Marchyshyn S, et al. Comparison of Phenolic Metabolites in Purified Extracts of Three Wild-Growing Herniaria L. Species and Their Antioxidant and Anti-Inflammatory Activities In Vitro. Molecules. 2022,27(2). doi: 10.3390/molecules27020530Read this paper
- Liu Y, Li C, Yang Y, et al. The TGF-β/miR-31/CEACAM1-S axis inhibits CD4(+) CD25(+) Treg differentiation in systemic lupus erythematosus. Immunol Cell Biol. 2021,99(7):697-710. doi: 10.1111/imcb.12449Read this paper



